Biomarkers in Neuroimaging


Neuroimaging has helped to elucidate that substance-use disorders are associated with changes in brain structure, function, and neurochemistry. Neuroimaging studies have improved our understanding of the neural correlates of addiction and how these relate to addictive behavior. Nevertheless, the potential impact of neuroimaging on treatment development for addictions has yet to be fully realized. Despite substantial advances, treatments are often not fully effective, and addiction continues to be a major public health burden . Neuroimaging has contributed to our appreciation of the complexity of addiction, highlighting the need for measurable indices, or biomarkers, of addiction to improve treatment outcomes. A “biomarker” typically refers to a measurable indicator of normal or abnormal biological processes or response to treatment . In substance-abuse research, biomarkers are needed to clarify how or why a treatment has an effect, on whom and under what circumstances.



Recent advances in neuroimaging are affording greater opportunities to identify brain biomarkers that might be used to improve outcomes of treatment for substance-use disorders. Neuroimaging is a critical tool in biomarker development because it relates neural circuits to both molecular mechanisms and behavior or clinical variation. In particular, neuroimaging studies are central to an emerging research effort to identify cross-diagnostic processes in substance-use and related disorders based on both behavior and neural circuits . In this work, alterations in brain activation patterns related to dimensions of functioning in individuals with addictions may be considered to represent abnormal processing associated with addictive behavior. Such research holds significant potential for identifying targets for treatment, detecting subgroups for treatment selection, and/or predicting treatment response . As disorder heterogeneity and individual variation pose significant challenges for delivering effective treatment, considering addictions in terms of dimensions of functioning may help to elucidate factors relevant to treatment response and lead to more specific, more effective treatments . This paper reviews neuroimaging research seeking to identify potential biomarkers of treatment response from several dimensions of functioning relevant to addiction:, impulsivity, and cognitive control.



 


    Related Conference of Biomarkers in Neuroimaging

    June 07-08, 2021

    Global Summit on Neurology

    Chicago, USA
    June 14-15, 2021

    35th European Neurology Congress

    London, UK
    June 28-29, 2021

    13th International Conference on Vascular Dementia

    Prague, Czech Republic
    July 05-06, 2021

    World Congress on Neurorehabilitation

    Paris, France
    July 13-14, 2021

    12th World Congress on Alzheimers Disease & Dementia

    Bangkok, Thailand
    July 19-20, 2021

    15th World Congress on Hematology and Oncology

    Tokyo, Japan
    July 19-20, 2021

    14th Asia Pacific Pediatrics Congress

    Singapore City, Singapore
    July 19-20, 2021

    World Conference on Addiction Psychiatry

    Madrid, Spain
    July 26-27, 2021

    8th International Conference on ENT Surgery

    London, Aland Islands
    August 16-17, 2021

    1st World Congress on Sleep Disorders and Therapeutics

    Berlin, Germany
    August 27-28, 2021

    12th International Conference on Dementia and Dementia Care

    Amsterdam, Netherlands
    September 02-03, 2021

    27th World Congress on Neurology and Neurodisorders

    Brisbane, Australia
    September 06-07, 2021

    7th World Congress on Parkinsons & Huntington Disease

    Rome, Italy
    September 08-09, 2021

    World Neuroscience Summit

    London, UK
    September 22-23, 2021

    International Conference on Neurosurgery & Neurology

    Zurich, Switzerland
    September 24-25, 2021

    2nd World Neurologist Congress

    Miami, USA
    September 28-29, 2021

    CARDIACSURGERY CARDIO 2021

    Auckland, Newzealand
    September 28-29, 2021

    International Congress on Neurology

    Auckland, Newzealand
    October 06-07, 2021

    5th Global Congress on Spine and Spinal Disorders

    London, UK
    October 12-13, 2021

    World Congress on Tobacco and Smoking Cessation

    Sydney, Australia
    October 14-15, 2021

    Global Meet on Plant genomics and Biotechnology

    Manila, Philippines
    October 25-26, 2021

    16th World Conference on Pharmaceutical Chemistry

    Zurich, Switzerland
    October 28-29, 2021

    4th Head and Neck Conference: The Multidisciplinary Approach

    Amsterdam, Netherlands
    November 08-09, 2021

    3rd World Congress on Nursing Education & Management

    Vienna, Austria
    November 08-09, 2021

    9th World Congress on Depression and Anxiety

    Brisbane, Australia
    November 25-26, 2021

    16th Annual Congress on Neuroscience

    Amsterdam, Netherlands
    November 25-26, 2021

    15th International Conference on Neuroscience and Dementia

    Amsterdam, Netherlands
    December 01-02, 2021

    34th World Neuroscience and Neurology Conferences

    Rome, Italy
    December 03-04, 2021

    International Conference on Neurology and Psychiatry

    Paris, France
    December 13-14, 2021

    11th world congress on Mental Health and Neuro Infection

    Abu Dhabi, UAE
    December 15-16, 2021

    4th Annual Conference on Stroke and Neurological Disorders

    Prague, Czech Republic
    February 09-10, 2022

    31st World Congress on Neurology and Therapeutics

    London, UK

    Biomarkers in Neuroimaging Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in